TrademarkOpen
Search / United States / 98212613

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

MINSAVAN

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine…
Show more

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 6 Oct 2023
    Application filed
    New Application Entered
  2. 27 Dec 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 28 Dec 2023
    Approved for publication
    Approved For Pub - Principal Register
  4. 6 Feb 2024
    Published for opposition
    Published For Opposition
  5. 2 Apr 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  6. 4 Sep 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  7. 10 Mar 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  8. 2 Sep 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 28 events
2026-03-07Notice Of Approval Of Extension Request E-Mailed
2026-03-06Sou Teas Extension Received
2026-03-06Sou Extension 4 Filed
2026-03-06Sou Extension 4 Granted
2025-09-15Notice Of Approval Of Extension Request E-Mailed
2025-09-02Sou Teas Extension Received
2025-09-02Sou Extension 3 Filed
2025-09-02Sou Extension 3 Granted
2025-08-28Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
2025-08-28Attorney/Dom.rep.revoked And/Or Appointed
2025-08-28Teas Change Of Correspondence Received
2025-08-28Teas Withdrawal Of Attorney Received-Firm Retains
2025-03-11Notice Of Approval Of Extension Request E-Mailed
2025-03-10Sou Teas Extension Received
2025-03-10Sou Extension 2 Filed
2025-03-10Sou Extension 2 Granted
2024-09-04Sou Teas Extension Received
2024-09-04Sou Extension 1 Filed
2024-09-04Sou Extension 1 Granted
2024-09-04Notice Of Approval Of Extension Request E-Mailed
2024-04-02Noa Mailed - Sou Required From Applicant
2024-02-06Published For Opposition
2024-02-06Official Gazette Publication Confirmation E-Mailed
2024-01-17Notification Of Notice Of Publication E-Mailed
2023-12-28Approved For Pub - Principal Register
2023-12-27Assigned To Examiner
2023-12-21New Application Office Supplied Data Entered
2023-10-06New Application Entered

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; Pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; Pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; Vaccines for human use

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 8 Mar 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.